DELTA2 指导:随机对照试验目标差异选择与样本量计算及报告
本文介绍 DELTA2 指导中关于确定随机对照试验目标差异和样本量计算的关键信息。目标差异应由关键利益相关方认定为现实或重要,样本量计算确保试验有足够统计功效识别该差异。文章还提供了样本量计算后续报告的建议。
要点
- 随机对照试验需事先进行样本量计算,确保有高概率达到预设主要目标。
- 目标差异应被一个或多个关键利益相关方认为现实或重要。
- 样本量计算应确保试验有足够统计功效识别特定大小的差异。
核心结论
- 随机对照试验应基于关键利益相关方认可的现实或重要目标差异进行事先样本量计算,并规范报告。
研究设计与样本
- 本文呈现 DELTA2 指导中关于确定目标差异和样本量计算的关键信息,并给出样本量计算报告建议。
主要发现
- 样本量计算确保试验有高概率达到预设主要目标,并避免将试验负担施加于超过必要数量的患者。
- 指定一个或多个关键利益相关方认为现实或重要的目标差异,可满足科学关切并进一步回应伦理要求。
关键数值与推荐
- 目标差异应被一个或多个关键利益相关方认为现实或重要。
- 样本量计算应确保试验具有所需统计功效来识别特定大小的差异是否存在。
临床怎么用
- 设计随机对照试验时,应事先确定目标差异并进行样本量计算,以确保研究有足够统计功效。
- 报告样本量计算时,应遵循 DELTA2 指导提供的建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Randomised controlled trials are considered to be the best method to assess comparative clinical efficacy and effectiveness, and can be a key source of data for estimating cost effectiveness. Central to the design of a randomised controlled trial is an a priori sample size calculation, which ensures that the study has a high probability of achieving its prespecified main objective. Beyond pure statistical or scientific concerns, it is ethically imperative that an appropriate number of study participants be recruited, to avoid imposing the burdens of a clinical trial on more patients than necessary. The scientific concern is satisfied and the ethical imperative is further addressed by the specification of a target difference between treatments that is considered realistic or important by one or more key stakeholder groups. The sample size calculation ensures that the trial will have the required statistical power to identify whether a difference of a particular magnitude exists. In this article, the key messages from the DELTA2 guidance on determining the target difference and sample size calculation for a randomised controlled trial are presented. Recommendations for the subsequent reporting of the sample size calculation are also provided.
引用
- Cook JA, Julious SA, Sones W, et al. DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. BMJ. 2018. PMID: 30560792. doi:10.1136/bmj.k3750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。